MTRRX Mutual Fund

NAV$20.35

Fund Essentials - as of Mar 31, 2026

Net Assets
$69M
Expense Ratio
0.97%
Dividend Yield (Current)
8.30%
Holdings
961
Inception Date
Oct 31, 2003
Fund Family
MFS Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Monthly
SEC 30-Day Yield
PRO

Performance

YTD+4.52%
1 Year+8.87%
3 Year+7.65%
5 Year+4.06%
10 Year+6.57%

Asset Allocation

Stocks: 57.96%
Bonds: 40.26%
Cash: 1.70%
Other: 0.07%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
SCHWCharles Schwab Corp.2.56%
PFEPfizer, Inc.2.05%
MDT:IEMedtronic PLC1.85%
MSFTMicrosoft Corp1.79%
COPConocophillips Common Stock USD 0.011.75%
Top 10 Concentration: 18.27%Report Date: Mar 31, 2026
Download all 961 holdings for MTRRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
8.30%
Frequency
Monthly
Latest Distribution
$0.02
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how MTRRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

MTRRX Mutual Fund Overview

MTRRX Mutual Fund (MFS Total Return Fund Cl R2) is managed by MFS Investment Management with $69.5M in net assets. MTRRX expense ratio is 0.97%, holding 961 positions across sectors including Financials, Other, Health Care. Inception date: 2003-10-31.

MTRRX performance shows a YTD return of 4.52%. The 1-year return is 8.87% and the 5-year return is 4.06%. MTRRX dividend yield stands at 8.30%, paid monthly.

MTRRX top holdings include Charles Schwab Corp. (2.6%), Pfizer, Inc. (2.0%), Medtronic PLC (1.9%), Microsoft Corp (1.8%), Conocophillips Common Stock USD 0.01 (1.8%). View all MTRRX holdings, sector breakdown, or dividend history.

MTRRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. MTRRX alternatives are available via the screener, along with tax-loss harvesting opportunities.